Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
October-2015 Volume 12 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
October-2015 Volume 12 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Optimal compressive force accelerates osteoclastogenesis in RAW264.7 cells

  • Authors:
    • Takako Hayakawa
    • Yoshitaka Yoshimura
    • Takashi Kikuiri
    • Mino Matsuno
    • Tomokazu Hasegawa
    • Kumu Fukushima
    • Kenjiro Shibata
    • Yoshiaki Deyama
    • Kuniaki Suzuki
    • Junichiro Iida
  • View Affiliations / Copyright

    Affiliations: Department of Orthodontics, Hokkaido University Graduate School of Dental Medicine, Sapporo, Hokkaido 060‑8586, Japan, Department of Molecular Cell Pharmacology, Hokkaido University Graduate School of Dental Medicine, Sapporo, Hokkaido 060‑8586, Japan, Department of Pediatric Dentistry, Hokkaido University Graduate School of Dental Medicine, Sapporo, Hokkaido 060‑8586, Japan, Department of Pediatric Dentistry, Faculty of Dentistry, Tokushima University, Tokushima 770‑8504, Japan
  • Pages: 5879-5885
    |
    Published online on: July 29, 2015
       https://doi.org/10.3892/mmr.2015.4141
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Mechanical stress produced by orthodontic forces is a factor in the remodeling of periodontal ligaments (PDLs) and alveolar bone. It has been reported that the expression of a number of cytokines associated with osteoclastogenesis is upregulated when compressive forces act on osteoblasts and PDL cells. The present study investigated the effects of compressive forces on the formation of osteoclasts from the macrophage cell line RAW264.7. Compressive forces on osteoclasts were exerted using layers of 3, 5, 7, 9 or 14 glass cover slips on the 4th day of culture for 24 h. The number of osteoclasts was determined by counting the number of cells positive for tartrate-resistant acid phosphatase staining. Osteoclastogenesis advanced rapidly on days four and five. The number of osteoclasts with >8 nuclei peaked when the force of 7 slips was applied, which was therefore regarded as the optimal compressive force. Alterations in the expression of osteoclast-associated genes are associated with changes in the differentiation and fusion of macrophages in response to compressive forces; therefore, osteoclast-associated genes were assessed by reverse transcription quantitative polymerase chain reaction in the present study. The mRNA expression of osteoclast‑associated genes increased significantly after 3 h of optimal compression, whereas mRNA expression increased after 24 h in the control group. These findings suggested that osteoclastogenesis of macrophages was accelerated when an optimal compressive force was applied.

Introduction

The purpose of orthodontic treatment is to achieve optimal occlusion for an individual. Orthodontic forces generate mechanical stress and are a factor that brings about the remodeling of the periodontal ligament (PDL) and alveolar bone (1,2). The PDL contains ample vascular and cellular connective tissue, including Sharpey's fibers, fibroblasts, osteoblasts, osteoclast precursors and osteoclasts, and surrounds the roots of the teeth. Osteoclast precursors and osteoclasts are present on the alveolar bone.

Previous studies have revealed the response of osteoblasts and fibroblasts to various types of mechanical stimulation. Mechanical stimuli, including tensile force (3–5), compressive force (6,7), fluid flow (8), hydrostatic pressure (9), rotation-associated stress (10) and other stimuli (11,12), are influential factors in bone remodeling. Orthodontic forces comprise tensile and compressive forces, and lead to a marked compression of the region of the PDL which they are applied to (13).

Tensile forces exerted using a Flexercell tension system suppressed osteoclast differentiation and fusion (4,5). Furthermore, when compressive forces were applied to osteoblasts and PDL cells, essential factors that promote osteoclast differentiation and activation, including prostaglandin E2 (PGE2), interleukin (IL)-1β, IL-6, tumor necrosis factor (TNF)-α, receptor activator of nuclear factor κB ligand (RANKL) and macrophage colony-stimulating factor (M-CSF) (11,12), were upregulated. Numerous studies have reported that applying such forces leads to secretion of cytokines associated with bone resorption and formation (14,15). However, it has remained elusive whether direct compressive forces regulate osteoclastogenesis.

Osteoclasts are derived from the monocyte/macrophage lineage and are formed by the fusion of mononuclear precursors. RANKL is an essential factor for osteoclast differentiation and activation (16). RANKL is secreted by osteoblasts and stromal cells, and is bound to RANK (14). RANK is induced by M-CSF in osteoclastogenesis, and is an essential factor for the formation of mature osteoclasts (17). The murine macrophage cell line RAW264.7 expresses RANK and can differentiate into osteoclasts after RANKL stimulation without M-CSF (5). RANKL signaling induces the master transcription factor nuclear factor of activated T cells c1 (NFATc1). NFATc1 is an essential regulator for numerous osteoclast-specific genes associated with differentiation, fusion and bone resorption (18).

Therefore, the aim of the present study was to develop a method for applying compressive forces to RAW cells and to investigate their osteoclastogenesis induced by applying various magnitudes of force for various periods of up to 24 h.

Materials and methods

Cell culture

The murine monocyte/macrophage cell line RAW264.7 (TIB-71™; American Type Culture Collection, Manassas, VA, USA) was used as osteoclast precursors. RAW264.7 cells have been shown to differentiate into osteoclast-like cells in the presence of RANKL (5). Cells were cultured in Dulbecco's modified Eagle's medium (Wako, Osaka, Japan) containing 10% heat-inactivated fetal bovine serum (FBS; Invitrogen Life Technologies, Carlsbad, CA, USA) and 66.7 μg/ml kanamycin sulfate (Meiji Seika, Tokyo, Japan) at 37°C in a humidified atmosphere of 95% air and 5% CO2. Cells were seeded onto 100-mm standard dishes (BD Biosciences, Franklin Lakes, NJ, USA) and cultured overnight. 12-mm diameter glass cover slips (slips; Fisher Microscope Cover Glass; Thermo Fisher Scientific, Waltham, MA, USA) was placed into the wells of a 24-well culture plate (BD Biosciences). For osteoclast differentiation, RAW264.7 cells were transferred into the 24-well culture plates at 1.0×104 cells/well and were cultured in α-minimum essential medium (α-MEM; Wako) supplemented with 10% heat-inactivated FBS, 2 μM L-alanyl-L-glutamine (Wako), 284 μM L-ascorbic acid 2-phosphate (Sigma-Aldrich, St. Louis, MO, USA), 66.7 μg/ml kanamycin sulfate and 50 ng/ml RANKL (Oriental Yeast Co., Ltd., Tokyo, Japan) at 37°C in a humidified atmosphere of 95% air and 5% CO2. Medium containing these reagents was replaced every other day.

Reversal of cells on glass cover slips

Prior to culture, 15 mm-diameter silicone tubes were cut into 2-mm slices and sterilized in an autoclave (Fig. 1A). RAW264.7 cells were cultured on slips which had been placed on sliced silicone tubes in 24-well culture plates for five days, and the slips were reversed in the same wells filled with culture medium after three days for 48 h, or after four days for 24 h (Fig. 1B). The control group was cultured for the same period without reversing the slips.

Figure 1

Cell culture. (A) Silicone tubes (15-mm diameter) were cut into 2-mm slices and sterilized in an autoclave. (B) RAW264.7 cells were cultured on 12 mm-diameter glass cover slips. These slips were placed on sliced silicon tubes in 24-well culture plates. The slips with RAW264.7 cells attached were then reversed on the sliced silicone tubes using sterilized forceps to face downwards. (C) Scheme of cell culture methods for applying compressive force. RAW264.7 cells on glass cover slips were cultured in 24-well culture plates. The glass cover slips with cells attached were reversed to face a collagen gel layer at the bottom of the well using sterilized forceps. (D) Reversed cells were continuously compressed by layered slips.

Preparation of collagen gels

Acid-soluble collagen solution (Cellmatrix; Nitta Gelatin, Inc., Osaka, Japan), ten-fold concentrated α-MEM (Invitrogen Life Technologies), and reconstruction buffer (2.2 g NaHCO3 and 4.77 g 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid in 100 ml 0.05 N NaOH; Nittal Gelatin, Inc.) were mixed at a volume ratio of 8:1:1, and 10% heat-inactivated FBS, 284 µM l-ascorbic acid 2-phosphate (Sigma-Aldrich) and 2 mM L-alanyl-L-gluta-mine (Wako) were added in an ice-cold bath kept at <4°C. This prepared collagen mixture was added to 24-well culture plates at a volume of 500 µl/well, and was subjected to gelation in a CO2 incubator at 37°C for 30 min. After the collagen mixture had solidified, it was covered with 50 ng/ml RANKL in culture medium at 1 ml/well.

Application of compressive forces

Prior to the application of compressive forces, RAW264.7 cells were incubated on the slip for three days (Fig. 1C, left). Collagen gel layers were prepared in other 24-well culture plates. Subsequently, osteoclasts on the slips were reversed and placed on top of these collagen gel layers (Fig. 1C, right), and were continuously compressed with layers of 3, 5, 7, 9 or 14 slips (~43 mg/slip) for 24 h, respectively (Fig. 1D). In the control group, the slips with cells attached were reversed onto the collagen gel layer without application of any additional force (Fig. 1C, right).

Tartrate-resistant acid phosphatase (TRAP) staining

After cells were compressed for the indicated times, they were fixed in 10% neutral formalin. They were then washed with distilled water and stained with Fast Red Violet LB Salt (Sigma-Aldrich) in TRAP staining solution [acetate buffer (pH 5.0) (Sigma-Aldrich), naphthol AS-MX phosphate (Sigma-Aldrich) as a substrate, red violet LB (Sigma-Aldrich) as a stain, and 50 mM sodium tartrate (Wako)]. TRAP-positive cells with 2–7 nuclei were considered to be small osteoclasts, and those with >8 nuclei were considered to be large osteoclasts (3,4). Osteoclasts were counted under a light microscope (magnification, ×100; Olympus IMT-2; Olympus, Tokyo, Japan) in a 20-mm2 rectangle within the circular field.

Pit assay

Osteologic™ was used to characterize and quantify osteoclast-mediated bone resorption in order to determine the amount of osteoclastic differentiation. A disc (φ12-m m) made of Osteologic™ (BD Biosciences) was coated with calcium phosphate. Osteoclasts were cultured for three days on these discs under normal cell culturing conditions as described above, and discs were reversed onto the top of a collagen gel layer in 24-well culture plates on the fourth day for 24 has a control group. Another group of reversed osteoclasts was subjected to the compressive force of seven layered slips. On the fifth day, the control and compressed osteoclasts on the discs were rinsed twice with distilled water. Subsequently, 1 ml bleach solution (6% NaOCl and 5.2% NaCl) was added to each well, followed by pipetting up and down to remove cells and incubation for five minutes at room temperature. Discs were washed with 2 ml distilled water three times and were examined by light microscopy (magnification, ×100; Olympus IMT-2; Olympus) after drying (19,20). The resorption area was measured using Image J software (v. 1.48a; National Institutes of Health, Bethesda, MD, USA).

Reverse transcription quantitative polymerase chain reaction (RT-qPCR)

Cells were compressed for 1, 3, 6, 12 and 24 h in 24-well culture plates. Total RNA was extracted using TRIzol (Invitrogen Life Technologies) according to the manufacturer's instructions. Reverse transcription of 1 µg RNA was performed to obtain cDNA. The PCR reaction mixture contained 50 mM Tri-Hcl (pH 7.5), 100 mM NaCl, 0.1 mM EDTA, 10 mM dithiothreitol, 0.01% Nonidet® P-40 and 50% glycerol. The thermocycling protocol was as follows: Annealing at 30°C for 10 min, enzyme reaction at 42°C for 20 min, denaturation at 99°C for 5 min and cooling at 4°C. cDNA was amplified using Rever Tra Ace-α FSK-101 (Toyobo, Osaka Japan). Primers (Applied Biosystems, Thermo Fisher Scientific) for the following genes were used: NFATc1 (Mm00479445_m 1), TRAP (Mm00475698_m1), RANK (Mm00437135_m matrix metalloproteinase-9 (MMP-9; Mm00432271_m1), dendritic cell specific trans membrane protein (DC-STAMP; Mm01168058_m1), osteoclast stimulatory trans membrane protein (OC-STAMP; Mm00512445_m1), integrin-av (Mm00434506_m1), integrin-β3 (Mm00443980_m1), cathepsin-K (cath-K; Mm00484036_m1), chloride channel 7 (ClC-7; Mm00442400_m1), adenosine triphosphatase H+ transporting vacuolar proton pump member I (ATP6i; Mm00469395_g1) and GAPDH (Mm99999915_g1). Real-time PCR was performed using the ABI Prism 7300 sequence detection system (Applied Biosystems). Data obtained for each sample were standardized against the expression of GAPDH and were calculated using the 2−ΔΔCt method (21, 22).

Statistical analysis

Values are expressed as the mean ± standard deviation. Statistical analysis was performed using Microsoft Excel for Mac 2011, version 14.4.8 (Redmont, WA, USA). Comparisons between two groups were analyzed using the two-tailed unpaired Student's t-test. P<0.05 was considered to indicate a statistically significant difference.

Results

Ostoclastogenesis increases with culturing time

In order to determine at what time-point osteoclast differentiation and fusion of RAW264.7 cells were activated, the number of osteoclasts and the number of nuclei per cell were monitored for five days (Fig. 2). RAW264.7 cells were cultured with 50 ng/ml RANKL in 24-well culture plates for five days to induce osteoclastonenesis. No osteoclasts were identified on day two, while the number of osteoclasts was slightly increased on days three and four, and was markedly increased on day five (Fig. 2A). Osteoclasts contained 2–4 nuclei on day three and began to appear with >5 nuclei on day four. On day five, the number of multinuclear cells further increased, and cells with >6 nuclei were increasingly present (Fig. 2B). Only upon osteoclastic differentiation, RQW264.7 cells begin to adhere to the cover slips. Day five was therefore determined to be the ideal time-point for reversing the cover slips in order to apply compressive forces on the cells.

Figure 2

Number of osteoclasts on each culture day up to day five. (A) The number of osteoclasts was assessed daily over five days. (B) The number of osteoclasts with multiple nuclei on days 2–5. (C) Number of small (2–7 nuclei) and large (>8 nuclei) osteoclasts in response to reversal of slips at either 24 or 48 h when compared with control group on day five. The control group was cultured on slips without reversing and was fixed on day five. The number of cells positive for tartrate-resistant acid phosphatase staining with 2–7 nuclei and those with >8 nuclei was counted. Values are expressed as the mean ± standard deviation (n=4).

Reversed culture without application of compressive forces does not affect osteoclastogenesis

The present study investigated the effects of reversing the slips on osteoclastogenesis on sliced silicone tubes for 24 and 48 h (Fig. 1B). Controls were cultured on slips without reversing and were fixed on day 5. The number of TRAP-positive cells with 2–7 nuclei and those with >8 nuclei was counted. The number of osteoclasts among the reversed cells showed no significant difference when compared with that in the control group at either 24 h or 48 h (Fig. 2C).

A compressive force exerted by loading with seven cover slips for 24 h accelerates osteoclastogenesis

Various intensities of compressive force were applied to osteoclasts for 24 h after 4–5 days of culture. RAW264.7 cells on slips were cultured as described above. Cells were reversed onto the collagen gel layer in other plates on the 4th day. Cells were then loaded with layers of 3–14 slips after being reversed. The number of osteoclasts was significantly increased when the cells were compressed with seven slips (Fig. 3A), and the number of osteoclasts with >8 nuclei was significantly elevated (Fig. 3B).

Figure 3

Effects of various compressive forces for 24 h on osteoclastogenesis. RAW264.7 cells (1.0×104 cells/well) on slips were pre-cultured with culture medium containing 50 ng/ml receptor activator of nuclear factor kappa-B ligand in 24-well culture plates for three days. Cells on slips were reversed onto the collagen gel layer after four days. Compressive force was applied with 3, 5, 7, 9 and 14 layered slips for 24 h from days four to five, while the control group was not loaded. (A) Total numbers of osteoclasts. (B) Number of small (2–7 nuclei) and large (>8 nuclei) osteoclasts. Values are expressed as the mean ± standard deviation (n=4). *P<0.05 vs. control. (C) Pit assay. RAW264.7 cells on Osteologic™ discs were pre-cultured in 24-well culture plates for three days. Cells on the discs were reversed onto collagen gel layers after four days. Compressive force was applied via 3–14 layered slips for 24 h from days four to five, while the control group was not subjected to loading. Light micrographs of Osteologic™ discs (magnification, ×100). Resorption areas of the discs in the control and CF groups are shown. (D) The resorption area in C was quantified using Image J software. Values are expressed as the mean ± standard deviation (n=3). **P<0.01 vs. control. CF, compressive force.

Bone resorption activity of osteoclasts subjected to compres-sive forces with 7 slips

The present study then examined the bone resorption activity of osteoclasts when the cells were subjected to a compressive force of seven slips. RAW264.7 cells were cultured on Osteologic™ discs as described above. Light micrographs of the Osteologic™ discs of the control and compressed (CF) groups were captured (Fig. 3C). The areas in which the calcium phosphate on the discs was completely resorbed were measured. Quantification of the results showed that the resorption areas in the compressed group were significantly larger when compared with those in the control group (Fig. 3D).

Expression of osteoclast-associated mRNA

The present study examined the effects of compressive forces on mRNA levels of osteoclast-specific genes associated with differentiation, fusion and adherence using RT-qPCR analysis (Fig. 4). The analysis showed that the respective mRNA levels of osteoclast-associated genes, including NFATc-1, TRAP, RANK, cath-K, ClC7, MMP-9, ATP6i, DC-STAMP, OC-STAMP as well as Integrin-αv and -β3 (4), peaked at 3 h in the CF group, whereas the mRNA levels peaked at 24 h in the control group.

Figure 4

Effects of compressive force on mRNA levels of osteoclast-associated genes. Force was applied to cells for 1–24 h. mRNA levels of osteoclast-associated genes were evaluated by reverse transcription quantitative polymerase chain reaction. The control group, which was cultured for the same duration without compressive force, was defined as the standard. Values are expressed as the mean ± standard deviation (n=4). **P<0.01; *P<0.05 vs. control at the same time-point. CF, compressive force.

Discussion

The present study was the first, to the best of our knowledge, to directly apply compressive forces to osteoclast-precursor cells using the abovementioned method. It was shown that application of the optimal compressive force to RAW264.7 cells led to an upregulation of the expression of various osteoclast-associated genes and promoted osteoclast differentiation and fusion. Under normal culturing conditions and stimulation with RANKL, osteoclastogenesis advanced rapidly on days four and five. A previous study demonstrated that small osteoclasts with 2–7 nuclei appeared on the third day (22). Previous studies also showed that formation of osteoclasts continued to increase up to the sixth day (22,23) and cells began to undergo apoptosis from the seventh day (3). Therefore, the present study applied compressive forces to the cells after 4–5 days of culture under osteoclastic induction conditions.

In a pilot study, compressive force was applied using layered glass cover slips on osteoclasts cultured on a 24-well culture plate. However, cell counts markedly decreased due to the hindered supply of culture medium to the cells. Therefore, a collagen gel (Cellmatrix) was used, against which cells were pressed in subsequent experiments. The technical manual for collagen gel noted that the gel was developed for tissue culture, allowing it to be used for the culture of various cells. Osteoclastogenesis was not promoted on the collagen gel, and cells merely underwent cell division to form a mass of mononucleated cells (results not shown). It was also observed that RAW264.7 cells differentiated and fused on rigid surfaces. The impaired osteoclast differentiation observed under these non-adherent conditions was due to the absence of RANK-dependent signaling by osteoclast precursors (24). When osteoclasts were cultured on the bottom of a 24-well culture plate subjected to compressive forces exerted by the collagen gel layer, it was difficult to determine the cell number under the light microscope and to measure mRNA expression in these osteoclasts.

The present study then cultured cells on slips and reversed them onto the collagen gel layer in order to compress the osteoclasts. Innutrition and cell death during application of compression was thereby avoided, and the collagen gel layer was able to act as a cushion material when compressive forces were applied to the osteoclasts. Studies have shown that osteoclast precursors and osteoclasts are present on alveolar bone and adjacent to compressed PDL (13,25), which suggested that compressive forces from orthodontic treatment are transmitted to osteoclasts on the alveolar bone via the PDL. Application of compressive forces to osteoclasts on slips via the collagen gel therefore represents an in vitro model of the application of orthodontic forces onto osteoclasts on the alveolar bone surface via the PDL in vivo.

As a control experiment, the present study examined the effects of reversing cover slips on osteoclast differentiation when compared with osteoclasts on the same slips without reversal. Differences in the numbers of osteoclasts with or without reversing were not detected in the absence of compressive forces.

The present study examined the effects of various weights (layers of 3–14 cover slips) on the number of osteoclasts. The number of osteoclasts and multinuclear cells was greatest when seven slips were used, which were therefore considered to exert the optimal compressive force. Furthermore, the optimal compressive force may have accelerated the fusion of osteoclasts. Application of this compressive force also accelerated osteoclastogenesis of RAW264.7 cells as compared with that in the control group. Bone resorption areas of osteoclasts on Osteologic™ discs were significantly elevated when the optimal compressive force was applied.

There are several types of tooth movement in orthodontic treatment, including tipping, bodily movement and rotation. The optimal orthodontic forces are different for each type of tooth movement and area of the root surface. Schwartz and Austria (26) recommended that the forces of orthodontic treatment should not exceed the capillary bed blood pressure (~20–26 g/cm2 of the root surface) for the most favorable outcomes. This is not in accordance with the results of the present study, in which a force of ~300 mg/cm2 exerted by eight cover slips was found to be optimal for accelerating osteoclastogenesis. Each tooth is attached to and separated from the adjacent alveolar bone by heavy collagen fibers known as Sharpey's fibers in the PDL (25). The optimal orthodontic force in teeth may therefore be diminished by Sharpey's fibers in the PDL.

In the present study, mRNA expression of osteoclast-associated genes, including NFATc-1, TRAP, RANK, cath-K, ClC7, MMP-9, ATP6i, DC-STAMP, OC-STAMP as well as Integrin-αv and -β3, was shown to be upregulated and accelerated by compression at the optimal force when compared with that in the controls. In the compressed group, the expression of the respective mRNAs peaked at 3 h, whereas in the control group mRNA expression increased slowly over 24 h. Among the genes assessed, NFATc1 is thought be an essential transcriptional factor for autoamplification. These results indicated that the optimal compressive force activates osteoclastogenesis and upregulates osteoclast-associated mRNA expression.

Numerous studies have suggested that applying compressive forces to osteoblasts and PDL cells promotes osteoclastogenesis. The present study succeeded in applying compressive forces to osteoclasts and found that the optimal compressive force accelerated osteoclastogenesis. These results provided the basis for an alternative approach to the consideration of optimal force, which focuses on osteoclast precursors and osteoclasts.

Acknowledgments

The authors are grateful to Dr. S. Kameyama (Departments of Orthodontics Dentistry, Hokkaido University Graduate School of Dental Medicine, Sapporo, Japan) for technical advice and support. This study was supported in part by the Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research (nos. 25463161 to Y.Y., 24659906 to T.K. and 24593071 to M.M.), and for Young Scientists (nos. 2586199403 to K.F. and 2586199303 to K.S).

References

1 

Bourauel C, Vollmer D and Jäger A: Application of bone remodeling theories in the simulation of orthodontic tooth movements. J Orofac Orthop. 61:266–279. 2000. View Article : Google Scholar : PubMed/NCBI

2 

Krisshnan V and Davidovitch Z: Cellular, molecular and tissue-level reactions to orthodontic force. Am J Orthod Dentofacial Orthop. 129:469.e1–e32. 2006. View Article : Google Scholar

3 

Suzuki N, Yoshimura Y, Deyama Y, Suzuki K and Kitagawa Y: Mechanical stress directly suppresses osteoclast differentiation in RAW264.7 cells. Int J Mol Med. 21:291–296. 2008.PubMed/NCBI

4 

Shibata K, Yoshimura Y, Kikuiri T, Hasegawa T, Taniguchi Y, Deyama Y, Suzuki K and Iida J: Effect of the release from mechanical stress on osteoclastogenesis in RAW264.7 cells. Int J Mol Med. 28:73–79. 2011.PubMed/NCBI

5 

Kameyama S, Yoshimura Y, Kameyama T, Kikuiri T, Matsuno M, Deyama Y, Suzuki K and Iida J: Short-term mechanical stress inhibits osteoclastogenesis via suppression of DC-STAMP in RAW264.7 cells. Int J Mol Med. 31:292–298. 2013.PubMed/NCBI

6 

Nishijima Y, Yamaguchi M, Kojima T, Aihara N, Nakajima R and Kasai K: Levels of RANKL and OPG in gingival crevicular fluid during orthodontic tooth movement and effect of compression force on releases from periodontal ligament cells in vitro. Orthod Craniofacial Res. 9:63–70. 2006. View Article : Google Scholar

7 

Ichimiya H, Takahashi T, Ariyoshi W, Takano H, Matayoshi T and Nishihara T: Compressive mechanical stress promotes osteoclast formation through RANKL expression on synovial cells. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 103:334–341. 2007. View Article : Google Scholar : PubMed/NCBI

8 

Tan SD, de Vries TJ, Kujipers-Jagtman AM, Semeins CM, Everts V and Klein-Nulend J: Osteocytes subjected to fluid flow inhibit osteoclast formation and bone resorption. Bone. 41:745–751. 2007. View Article : Google Scholar : PubMed/NCBI

9 

Rubin J, Biskobing D, Fan X, Rubin C, McLeod K and Taylor WR: Pressure regulates osteoclast formation and MCSF expression in marrow culture. J Cell Physiol. 170:81–87. 1997. View Article : Google Scholar : PubMed/NCBI

10 

Qing Hong Z, Meng Tao L, Yi Z, Wei L, Ju Xiang S and Li L: The effect of rotative stress on CAII, FAS, FASL, OSCAR and TRAP gene expression in osteoclasts. J Cell Biochem. 114:388–397. 2013. View Article : Google Scholar

11 

Makihira S, Kawahara Y, Yuge L, Mine Y and Nikawa H: Impact of the microgravity environment in a 3-dimentional clinostat on osteoblast- and osteoclast-like cells. Cell Biol Int. 32:1176–1181. 2008. View Article : Google Scholar : PubMed/NCBI

12 

Kadow-Romacker A, Hoffman JE, Duga G, Wildemann B and Schmidmaier G: Effect of mechanical stimulation on osteoblast and osteoclast-like cells in vitro. Cells Tissues Organs. 190:61–68. 2009. View Article : Google Scholar

13 

Graber LW, Vanarsdall RL and Vig KWL: Orthodontics; current principles and techniques. Fifth edition. Mosby & Co; Philadelphia, PA: pp. 247–286. 2012

14 

Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT and Martin TJ: Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev. 20:345–357. 1999. View Article : Google Scholar : PubMed/NCBI

15 

Boyle WJ, Simonet WS and Lacey DL: Osteoclast differentiation and activation. Nature. 423:337–342. 2003. View Article : Google Scholar : PubMed/NCBI

16 

Väänänen HK and Laitala-Leinonen T: Osteoclast lineage and function. Arch Biochem Biophys. 473:132–138. 2008. View Article : Google Scholar : PubMed/NCBI

17 

Yoshida H, Hayashi S, Kunusada T, Ogawa M and Nishikawa S, Okamura H, Sudo T, Shultz LD and Nishikawa S: The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature. 345:442–444. 1990. View Article : Google Scholar : PubMed/NCBI

18 

Takayanagi H: The role of NFAT in osteoclast formation. Ann N Y Acad Sci. 1116:227–237. 2007. View Article : Google Scholar : PubMed/NCBI

19 

Koshihara Y, Kodama S, Ishibashi H, Azuma Y, Ohta T and Karube S: Reversibility of alendronate-induced contraction in human osteoclast like cells formed from bone marrow cells in culture. J Bone Miner Metab. 17:98–107. 1999. View Article : Google Scholar

20 

Contractor T, Babiarz B, Kowalski A, Rittling SR, Sørensen ES and Denhardt DT: Osteoclasts resorb protein-free mineral (Osteologic discs) efficiently in the absence of osteopontin. In Vivo. 19:335–342. 2005.PubMed/NCBI

21 

Aguirre JI, Plotkin LI, Gortazar AR, Millan MM, O'Brien CA, Manolagas SC and Bellido T: A novel ligand independent function of the estrogen receptor is essential for osteocyte and osteoblast mechanotransduction. J Biol Chem. 282:25501–25508. 2007. View Article : Google Scholar : PubMed/NCBI

22 

Nomura M, Yoshimura Y, Kikuiri T, Hasegawa T, Taniguchi Y, Deyama Y, Koshiro K, Sano H, Suzuki K and Inoue N: Platinum nanoparticles suppress osteoclatogenesis through scavenging of reactive oxygen species produced in RAW264.7 cells. J Pharmacol Sci. 117:243–252. 2011. View Article : Google Scholar

23 

Abe K, Yoshimura Y, Deyama Y, Kikuiri T, Hasegawa T, Tei K, Shinoda H, Suzuki K and Kitagawa Y: Effect of bisphosphonates on osteoclastogenesis in RAW264.7 cells. Int J Mol Med. 29:1007–1015. 2012.PubMed/NCBI

24 

Mochizuki A, Takami M, Miyamoto Y, Nakamaki T, Tomoyasu S, Kadono Y, Tanaka S, Inoue T and Kamijo R: Cell adhesion signaling regulates RANK expression in osteoclast precursors. PLoS One. 7:e487952012. View Article : Google Scholar : PubMed/NCBI

25 

Profit WR, Fields HW Jr and Sarver DM: Contemporary Orthodontics. Fourth edition. Mosby; St Louis, MO: pp. 331–352. 2007

26 

Schwartz AM and Austria MDV: Tissure changes incidental to orthodontic tooth movement. Int J Orthod. 18:331–352. 1932.

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Hayakawa T, Yoshimura Y, Kikuiri T, Matsuno M, Hasegawa T, Fukushima K, Shibata K, Deyama Y, Suzuki K, Iida J, Iida J, et al: Optimal compressive force accelerates osteoclastogenesis in RAW264.7 cells. Mol Med Rep 12: 5879-5885, 2015.
APA
Hayakawa, T., Yoshimura, Y., Kikuiri, T., Matsuno, M., Hasegawa, T., Fukushima, K. ... Iida, J. (2015). Optimal compressive force accelerates osteoclastogenesis in RAW264.7 cells. Molecular Medicine Reports, 12, 5879-5885. https://doi.org/10.3892/mmr.2015.4141
MLA
Hayakawa, T., Yoshimura, Y., Kikuiri, T., Matsuno, M., Hasegawa, T., Fukushima, K., Shibata, K., Deyama, Y., Suzuki, K., Iida, J."Optimal compressive force accelerates osteoclastogenesis in RAW264.7 cells". Molecular Medicine Reports 12.4 (2015): 5879-5885.
Chicago
Hayakawa, T., Yoshimura, Y., Kikuiri, T., Matsuno, M., Hasegawa, T., Fukushima, K., Shibata, K., Deyama, Y., Suzuki, K., Iida, J."Optimal compressive force accelerates osteoclastogenesis in RAW264.7 cells". Molecular Medicine Reports 12, no. 4 (2015): 5879-5885. https://doi.org/10.3892/mmr.2015.4141
Copy and paste a formatted citation
x
Spandidos Publications style
Hayakawa T, Yoshimura Y, Kikuiri T, Matsuno M, Hasegawa T, Fukushima K, Shibata K, Deyama Y, Suzuki K, Iida J, Iida J, et al: Optimal compressive force accelerates osteoclastogenesis in RAW264.7 cells. Mol Med Rep 12: 5879-5885, 2015.
APA
Hayakawa, T., Yoshimura, Y., Kikuiri, T., Matsuno, M., Hasegawa, T., Fukushima, K. ... Iida, J. (2015). Optimal compressive force accelerates osteoclastogenesis in RAW264.7 cells. Molecular Medicine Reports, 12, 5879-5885. https://doi.org/10.3892/mmr.2015.4141
MLA
Hayakawa, T., Yoshimura, Y., Kikuiri, T., Matsuno, M., Hasegawa, T., Fukushima, K., Shibata, K., Deyama, Y., Suzuki, K., Iida, J."Optimal compressive force accelerates osteoclastogenesis in RAW264.7 cells". Molecular Medicine Reports 12.4 (2015): 5879-5885.
Chicago
Hayakawa, T., Yoshimura, Y., Kikuiri, T., Matsuno, M., Hasegawa, T., Fukushima, K., Shibata, K., Deyama, Y., Suzuki, K., Iida, J."Optimal compressive force accelerates osteoclastogenesis in RAW264.7 cells". Molecular Medicine Reports 12, no. 4 (2015): 5879-5885. https://doi.org/10.3892/mmr.2015.4141
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team